Spire Healthcare Group plc (LON:SPI - Get Free Report) shares rose 13.4% on Friday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 245.50 ($3.32). Approximately 40,970,105 shares traded hands during mid-day trading, an increase of 2,397% from the average daily volume of 1,640,628 shares. The stock had previously closed at GBX 216.50 ($2.93).
Wall Street Analyst Weigh In
SPI has been the topic of a number of analyst reports. JPMorgan Chase & Co. dropped their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a research note on Tuesday, August 5th. Berenberg Bank restated a "buy" rating and issued a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Spire Healthcare Group has an average rating of "Buy" and an average price target of GBX 294.33.
View Our Latest Stock Report on Spire Healthcare Group
Spire Healthcare Group Price Performance
The stock has a market capitalization of £981.79 million, a price-to-earnings ratio of 5,304.35, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The stock has a 50-day simple moving average of GBX 218.99 and a 200 day simple moving average of GBX 203.96.
Spire Healthcare Group (LON:SPI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities research analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.
Spire Healthcare Group Company Profile
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.